Report on the 12th International Society of Blood Transfusion platelet immunology workshop

Background and Objectives  The aims of the 12th International Society of Blood Transfusion (ISBT) Platelet Immunology Workshop were to evaluate the proficiency of molecular human platelet antigen (HPA) genotyping and detection of platelet antibodies of unusual specificity or reactivity, to assess whether quantification of anti‐HPA‐1a is practicable, and to determine the variability of reagents and components used in the monoclonal antibody immobilization of platelet antigens assay (MAIPA).

[1]  W. Ouwehand,et al.  Collaborative study to establish the first international standard for quantitation of anti‐HPA‐1a , 2005, Vox sanguinis.

[2]  R. Aster,et al.  Human platelet antigen‐specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia , 2004, Transfusion.

[3]  B. Colvin,et al.  ES04.01 
Physiology of haemostasis , 2004 .

[4]  R. W. Huff,et al.  Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays , 2003, Transfusion.

[5]  M. Goldman,et al.  Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop , 2003, Vox sanguinis.

[6]  C. Tzeng,et al.  PCR with sequence‐specific primer‐based simultaneous genotyping of human platelet antigen‐1 to ‐13w , 2002, Transfusion.

[7]  W. Ouwehand,et al.  Genotyping for platelet‐specific antigens: techniques for the detection of single nucleotide polymorphisms , 2002, Vox sanguinis.

[8]  W. Ouwehand,et al.  A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. , 2002, Blood.

[9]  S. Panzer.  Report on the Tenth International Platelet Genotyping and Serology Workshop on behalf of the International Society of Blood Transfusion , 2001, Vox sanguinis.

[10]  W. Ouwehand,et al.  Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA‐5 alloantigens , 2000, British journal of haematology.

[11]  H. Ohto,et al.  Anti‐HPA‐5b‐induced neonatal alloimmune thrombocytopenia: antibody titre as a predictor , 2000, British journal of haematology.

[12]  W. Ouwehand,et al.  Management of severe alloimmune thrombocytopenia in the newborn , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[13]  J. Bussel,et al.  The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. , 1998, Bailliere's clinical haematology.

[14]  H. Hackstein,et al.  DNA typing of human platelet antigen systems 1, 2, 3 and 5 in B-lymphoblastoid cell lines of the International Histocompatibility Workshop. , 1997, Tissue antigens.

[15]  C. Chapman,et al.  HPA genotyping by PCR sequence‐specific priming (PCR–SSP): a streamlined method for rapid routine investigations , 1997, Transfusion medicine.

[16]  S. Panzer,et al.  Rapid Typing for Human Platelet Antigen Systems ‐1, ‐2, ‐3 and ‐5 by PCR Amplification with Sequence‐Specific Primers , 1996, Vox sanguinis.

[17]  S. Slichter,et al.  Report on the Sixth International Society of Blood Transfusion Platelet Serology Workshop , 1996, Transfusion.

[18]  D. Liang,et al.  Neonatal Alloimmune Thrombocytopenia in Taiwan Due to an Antibody against a Labile Component of HPA‐3a (Bak) , 1995, Vox sanguinis.

[19]  D. Bellissimo,et al.  Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele‐specific primers , 1994, Transfusion.

[20]  C. Mueller-Eckhardt,et al.  Report on the Fifth International Society of Blood Transfusion Platelet Serology Workshop , 1993, Transfusion.

[21]  V. Blanchette,et al.  Management of Alloimmune Neonatal Thrombocytopenia , 1989, The Lancet.

[22]  A. Dawson.  Bailliere's Clinical Haematology - International Practice and Research , 1988 .

[23]  V. Kiefel,et al.  Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. , 1987, Blood.